rs398123102
Variant summary
Our verdict is Pathogenic. The variant received 18 ACMG points: 18P and 0B. PM1PM2PM5PP3_StrongPP5_Very_Strong
The NM_000033.4(ABCD1):c.1553G>A(p.Arg518Gln) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.000000912 in 1,096,719 control chromosomes in the GnomAD database, with no homozygous occurrence. There are no hemizygote samples in GnomAD. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R518W) has been classified as Likely pathogenic.
Frequency
Consequence
NM_000033.4 missense
Scores
Clinical Significance
Conservation
Publications
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 18 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ABCD1 | ENST00000218104.6 | c.1553G>A | p.Arg518Gln | missense_variant | Exon 6 of 10 | 1 | NM_000033.4 | ENSP00000218104.3 | ||
ABCD1 | ENST00000443684.2 | n.556G>A | non_coding_transcript_exon_variant | Exon 5 of 6 | 3 | |||||
PLXNB3-AS1 | ENST00000434284.1 | n.72-1578C>T | intron_variant | Intron 1 of 2 | 3 |
Frequencies
GnomAD3 genomes Cov.: 24
GnomAD2 exomes AF: 0.00000548 AC: 1AN: 182400 AF XY: 0.00 show subpopulations
GnomAD4 exome AF: 9.12e-7 AC: 1AN: 1096719Hom.: 0 Cov.: 32 AF XY: 0.00 AC XY: 0AN XY: 362213 show subpopulations
GnomAD4 genome Cov.: 24
ClinVar
Submissions by phenotype
Adrenoleukodystrophy Pathogenic:7
This sequence change replaces arginine, which is basic and polar, with glutamine, which is neutral and polar, at codon 518 of the ABCD1 protein (p.Arg518Gln). This variant is present in population databases (rs398123102, gnomAD 0.001%). This missense change has been observed in individual(s) with ABCD1-related conditions (PMID: 10190819, 12175782, 15811009, 16087056, 21068741, 21700483, 22479560, 23419472, 23566833, 26260157). In at least one individual the variant was observed to be de novo. This variant is also known as c.1939G>A. ClinVar contains an entry for this variant (Variation ID: 92317). Invitae Evidence Modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) indicates that this missense variant is expected to disrupt ABCD1 protein function with a positive predictive value of 95%. This variant disrupts the p.Arg518 amino acid residue in ABCD1. Other variant(s) that disrupt this residue have been determined to be pathogenic (PMID: 14767898, 16415970). This suggests that this residue is clinically significant, and that variants that disrupt this residue are likely to be disease-causing. For these reasons, this variant has been classified as Pathogenic. -
- -
- -
- -
PM2_Supporting+PS4+PM6+PP4+PM5 -
Variant summary: ABCD1 c.1553G>A (p.Arg518Gln) results in a conservative amino acid change located in the AAA+ ATPase domain (IPR003593) of the encoded protein sequence. Four of five in-silico tools predict a damaging effect of the variant on protein function. The variant allele was found at a frequency of 5.5e-06 in 182500 control chromosomes (gnomAD). The variant c.1553G>A (also known as 1939G>A) has been reported in the literature in numerous individuals affected with Adrenoleukodystrophy (e.g. Imamura_1997, Takano_1999, Dvorakova_2001, Guimaraes_2002, Pan_2005, Coll_2005, Wiens_2019), and in several cases the lack of ALD protein in patient derived fibroblasts was demonstrated (e.g. Imamura_1997, Guimaraes_2002, Coll_2005). These data indicate that the variant is very likely to be associated with disease. Two clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar after 2014, and both of them classified the variant as pathogenic. Based on the evidence outlined above, the variant was classified as pathogenic. -
- -
not provided Pathogenic:5
- -
- -
- -
Not observed at significant frequency in large population cohorts (gnomAD); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 16996397, 25920484, 12175782, 23566833, 33920672, 30968598, 34826210, 21068741, 16415970, 20661612, 16087056, 27766264, 26260157, 11438993, 15811009, 23346902, 10190819, 27991992, 31074578, 32798492, 23419472, 24719486, 22479560, 15642351) -
ABCD1: PM1, PM2, PS4:Moderate, PM5:Supporting, PP3, PP4, PS3:Supporting -
ABCD1-related disorder Pathogenic:1
The ABCD1 c.1553G>A variant is predicted to result in the amino acid substitution p.Arg518Gln. This variant has been reported in multiple individuals with X-linked adrenoleukodystrophy (see for example, Table 3, Ping et al. 2006. PubMed ID: 16415970; Table 1, Coll et al. 2005. PubMed ID: 15811009; Table 2, Matsukawa et al. 2011. PubMed ID: 20661612). This variant is reported in 0.0012% of alleles in individuals of European (non-Finnish) descent in gnomAD. Alternate missense variants affecting the same amino acid (p.Arg518Trp and p.Arg518Gly) have been reported to be causative for X-linked adrenoleukodystrophy (Table 3, Ping et al. 2006. PubMed ID: 16415970; Table 2, Matsukawa et al. 2011. PubMed ID: 20661612). This variant is interpreted as pathogenic. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at